5-126592663-C-T
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PVS1_ModeratePP5_Very_Strong
The NM_001182.5(ALDH7A1):c.312+1G>A variant causes a splice donor, intron change. The variant allele was found at a frequency of 0.0000242 in 1,613,592 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001182.5 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- pyridoxine-dependent epilepsyInheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Illumina, Orphanet, ClinGen
- pyridoxine-dependent epilepsy caused by ALDH7A1 mutantInheritance: AR, AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ALDH7A1 | NM_001182.5 | c.312+1G>A | splice_donor_variant, intron_variant | Intron 3 of 17 | ENST00000409134.8 | NP_001173.2 | ||
| ALDH7A1 | NM_001201377.2 | c.228+1G>A | splice_donor_variant, intron_variant | Intron 3 of 17 | NP_001188306.1 | |||
| ALDH7A1 | NM_001202404.2 | c.312+1G>A | splice_donor_variant, intron_variant | Intron 3 of 15 | NP_001189333.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ALDH7A1 | ENST00000409134.8 | c.312+1G>A | splice_donor_variant, intron_variant | Intron 3 of 17 | 1 | NM_001182.5 | ENSP00000387123.3 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152204Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000318 AC: 8AN: 251426 AF XY: 0.0000515 show subpopulations
GnomAD4 exome AF: 0.0000260 AC: 38AN: 1461388Hom.: 0 Cov.: 30 AF XY: 0.0000316 AC XY: 23AN XY: 727040 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152204Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74354 show subpopulations
ClinVar
Submissions by phenotype
Pyridoxine-dependent epilepsy Pathogenic:3
- -
- -
This sequence change affects a donor splice site in intron 3 of the ALDH7A1 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in ALDH7A1 are known to be pathogenic (PMID: 16491085, 20554659). This variant is present in population databases (rs199497486, gnomAD 0.02%). Disruption of this splice site has been observed in individual(s) with pyridoxine-dependent epilepsy (PMID: 21733724). It has also been observed to segregate with disease in related individuals. This variant is also known as c.311+1G>A. ClinVar contains an entry for this variant (Variation ID: 265384). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
Neonatal seizure Pathogenic:1
homozygous -
not provided Pathogenic:1
Canonical splice site variant expected to result in aberrant splicing, although in the absence of functional evidence the actual effect of this sequence change is unknown.; This variant is associated with the following publications: (PMID: 25525159, 21733724, 30043187) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at